PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide

• Shimpei Iikuni ,

  Roles Conceptualization, Funding acquisition, Writing – original draft

  * E-mail: iikuni@pharm.kyoto-u.ac.jp (SI); ono@pharm.kyoto-u.ac.jp (MO)

  Affiliation Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

  https://orcid.org/0000-0002-7073-9084

  ⨯
• Hiroyuki Watanabe,

  Roles Writing – review & editing

  Affiliation Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

  ⨯
• Yoichi Shimizu,

  Roles Writing – review & editing

  Affiliations Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan, Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Yuji Nakamoto,

  Roles Conceptualization, Writing – review & editing

  Affiliation Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Masahiro Ono

  Roles Conceptualization, Funding acquisition, Writing – review & editing

  * E-mail: iikuni@pharm.kyoto-u.ac.jp (SI); ono@pharm.kyoto-u.ac.jp (MO)

  Affiliation Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

  ⨯